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Abstract
 
Cytotoxic T lymphocyte–associated antigen 4 (CTLA-4) is an essential negative regulator of T
cell activation. Recent evidence suggests that CTLA-4 association with the immunological
synapse during contact with antigen-presenting cells is important for its inhibitory function. In
the present study, we observed a direct interaction of CTLA-4 with the phosphorylated form
of T cell receptor (TCR)
 
 
 
 within the glycolipid-enriched microdomains associated with the T
cell signaling complex. In this setting, CTLA-4 regulated the accumulation/retention of TCR
 
 
 
in the signaling complex, as the lipid raft fractions from CTLA-4KO T cells contained signifi-
cantly higher amounts of the TCR components when compared with wild-type littermates. In
contrast, coligation of CTLA-4 with the TCR during T cell activation selectively decreased
the amount of TCR
 
 
 
 that accumulated in the rafts. These results suggest that CTLA-4 func-
tions to regulate T cell signaling by controlling TCR accumulation and/or retention within
this a critical component of the immunological synapse.
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Introduction
 
T cell activation is regulated by a balance between positive
and negative signals mediated by a series of costimulatory
ligand–receptor pairs. While costimulatory pathways in-
volving molecules such as CD28, inducible costimulator
(ICOS), 4–1BB, and CD40L are essential coactivators of
proliferation, cytokine production, and migration, CTLA-4
and PD-1, homologues of CD28 family of cell surface re-
ceptors, provide strong negative signals (1). In particular,
CTLA-4 coligation with TCR has been shown to inhibit
IL-2 production, cell cycle progression, and proliferation.
In vivo, CTLA-4 knockout mice manifest fatal lympho-
proliferative phenotype and die within 4 wk of life (2, 3).
In spite of the importance of CTLA-4 in regulation of the
immune system, however, the molecular basis for this in-
hibitory function is still largely unknown.
The interface between the T cell and APC membranes
form the hot spot for T cell activation, a highly organized
ultra structure which is called the immunological synapse
(4, 5). The membrane lipid raft is biochemically character-
ized as a detergent insoluble glycosphingolipid enriched
microdomain that is considered as an essential component
of the immunologic synapse (6). After TCR engagement,
molecules critical for mediating activation signals, such as
Lck, Fyn, protein kinase C (PKC)
 
 
 
, phospholipase C
(PLC)
 
 
 
, and linker for activation of T cells (LAT), are all
recruited to the raft aggregates at the T cell–APC contact
area. More importantly, the TCR itself dynamically associ-
ates with raft upon receptor cross-linking, allowing the
accessibility of signaling molecules to TCR facilitating the
biochemical signals of activation. As such, pharmacological
disruption of the rafts abrogate early signal events in T cell
activation such as calcium influx, supporting the essential
role of raft integrity for T cell activation (7).
Recently, Darlington et al. (8) reported that CTLA-4 is
recruited to the raft during negative signaling. However, the
functional importance of this association was unclear. In the
present study, we analyzed the biochemical consequences of
the colocalization of CTLA-4 to the rafts. We report that
CTLA-4 forms a molecular complex with phosphorylated
 
TCR
 
 
 
 within the rafts. Furthermore, the overall levels of
TCR
 
 
 
, most prominently phosphorylated TCR
 
 
 
, in the
rafts is regulated by CTLA-4 as assessed in CTLA4KO T
cells and wild-type T cells after CTLA-4 cross-linking. To-
gether, these results support a proximal role for CTLA-4 in
attenuating TCR-mediated signal transduction which em-
phasizing that both positive and negative signaling events
impact on the early events of T cell activation.
 
Address correspondence to Dr. Jeffrey A. Bluestone, Diabetes Center,
University of California, 513 Parnassus Ave., Box 0540, San Francisco,
CA 94143-0540. Phone: 415-514-1683; Fax: 415-564-5813; E-mail:
jbluest@diabetes.ucsf.eduT
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Materials and Methods
 
Antibodies and Reagents.
 
Hamster anti–mouse CD3
 
 
 
 (145–
2C11), hamster anti–mouse CTLA-4 (UC10–4F10), anti–mouse
CD28 (PV-1), hamster anti–mouse 
 
  
 
 TCR (GL-3), hamster
anti–mouse class I (10H3), anti–B7–1(16–10A1), anti–B7–2(GL-
2), and rabbit polyclonal anti–CTLA-4 (9) were prepared in our
lab. Anti–mouse TCR
 
 
 
 (6B10.2: Santa Cruz Biotechnology,
Inc.), anti-Fyn (Fyn3; Santa Cruz Biotechnology), anti-phospho-
tyrosine (4G10: Upstate Biotechnology), goat anti–hamster (Cap-
pel), peroxidase-conjugated cholera toxin B subunit (Sigma-
Aldrich), and FITC-conjugated cholera toxin B subunit
(Sigma-Aldrich) were purchased. For mice T cell culture,
DMEM (Gibco) supplemented with 10% fetal calf serum, 10 mM
HEPES, nonessential amino acids (Biosource International), 55
 
 
 
M 2-mercaptoethanol, 100 
 
 
 
g/ml penicillin, and 100 U/ml
streptomycin was used as media.
 
Jurkat Cell Culture and Transfection of CTLA-4.
 
Wild-type
murine CTLA-4 cDNA was subcloned into the expression vec-
tor pBSR
 
 
 
EN and stably transfected into Jurkat E6.1 cell line.
Cells were maintained at 37
 
 
 
C in a 5% CO
 
2
 
 incubator in com-
plete RPMI medium (University of California at San Francisco
Cell Culture Facility), supplemented with 10% fetal calf serum
and 2 mg/ml G418 (Life Technologies) for drug selection.
 
Animals.
 
All the mice in this study were kept in a specific
pathogen-free animal barrier facility at the University of Califor-
nia at San Francisco. C57BL/6 (B6) mice were purchased from
Charles Rivers. CTLA-4 knockout mice, on the B6 background,
were maintained as F
 
1
 
 heterozygotes which were interbred to
generate the CTLA-4KO mice used in experiments. The mice
were screened within 24 h of birth by PCR of tail DNA using
the oligonucleotide primers for CTLA-4 (5
 
 
 
-ATGGTGTTG-
GCTAGCAGCCATG and 3
 
 
 
-TTGGATGGTGAGGTTCA-
CTC) and the neomycin resistance gene (5
 
 
 
-ATTGAACAA-
GATGGATTGCAC and 3
 
 
 
-CGTCCAGATCATCCTGATC).
The constitutive CTLA-4 Y201V-expressing transgenic mice
(10), a gift of Dr. Ellen Chuang, Cornell University School of
Medicine, New York, NY) were maintained on a mixed back-
ground.
 
Activation of CTLA-4 Knockout Mouse T Cells.
 
CTLA-4
knockout mice were treated by anti–B7–1 (100 
 
 
 
g) and anti–B7–2
(100 
 
 
 
g) antibody on days 8, 11, and 14 after their birth to inhibit
T cell activation and maintain the T cells in a naive state. The
mice were killed at day 21, and single cell suspensions of lymph
nodes were stimulated by plate-bound anti-CD3 and anti-CD28
(1 
 
 
 
g/ml each) in culture media for 48 h. Cells were then trans-
ferred to T-175 culture flasks with fresh medium supplemented
with 2 U/ml recombinant human IL-2. Live cells were enriched
by Ficoll density gradient 24 h later and used for experiments.
 
In Vitro Stimulation by Antibody Cross-linking.
 
Single cell sus-
pensions of mouse lymph nodes were stimulated by plate-bound
anti-CD3 (1 
 
 
 
g/ml) and anti-CD28 (1 
 
 
 
g/ml) for 60 to 70 h in
culture media, harvested, washed, and replated in T-175 culture
flasks in the presence of fresh medium and 20 U/ml recombinant
human IL-2. After 6 d, live cells were enriched by Ficoll density
gradient. An aliquot of 10
 
8
 
 cells was used for each stimulation
condition. Washed cells were resuspended in serum-free media at
the density of 2 
 
 
 
 10
 
8
 
 /ml. Cells were incubated with a mixture
of anti-CD3 in the presence of either anti–CTLA-4 or control
(anti-
 
  
 
 TCR) mAbs as indicated in figure legends. After incuba-
tion on ice for 20 min, surface bound antibodies were cross-
linked by adding anti–hamster antibodies at a final dilution of
1:100 for an additional 5 min. The reaction was stopped by add-
ing ice cold PBS containing 1 mM sodium orthovanadate.
 
Isolation of the Lipid Raft by Sucrose Density Gradient.
 
T cells
were stimulated as described above, pelleted, and resuspended
with 500 
 
 
 
l of ice-cold lysis buffer (final concentration: 0.2%
Triton X-100, 50 mM Tris [pH 7.6], 150 mM NaCl, 5 mM
EDTA, 1 mM Na
 
3
 
VO
 
4
 
, 10 
 
 
 
g/ml aprotinin, 10 
 
 
 
g/ml leupep-
tin, and 1 mM PMSF) on ice. The lysates were disrupted with 10
strokes using a Dounce cell homogenizer and mixed with an
equal volume of sucrose as an 85% solution in TNE buffer (20
mM Tris [pH 8.0], 150 mM NaCl, 50 mM EDTA). The suspen-
sion was transferred into an ultracentrifuge tube (Kendro Labora-
tory Products) where it was overlaid with 3 ml of 30% sucrose
and 1 ml of 5% sucrose both suspended in TNE. The tube was
then filled to the top with TNE buffer. These gradients were
spun for 12 to 16 h at 40,000 rpm in a SW-40 Ti swinging
bucket rotor at 4
 
 
 
C in a Beckman ultracentrifuge. After remov-
ing top TNE buffer, the gradients were harvested into six 0.8-ml
fractions from top to bottom. The GEMs were identified by dot
blot analysis of the cholera toxin B subunit as described (11).
The individual fractions were mixed with 0.1 volume of 0.6 M
n-octyl 
 
 
 
-D-galactopyranoside (final 60 mM), incubated for 2 h
to solubilize the rafts, and subjected to immunoprecipitation and
Western blot analyses.
 
Results and Discussion
 
CTLA-4 Localizes to Rafts Where It Selectively Interacts with
Accumulated Phosphorylated TCR
 
 
 
.
 
Several reports have
suggested that the lipid rafts are critical during T cell activa-
tion (for a review, see reference 6). However, the basis for
negative regulation of these complexes remains unclear. A
recent publication by Darlington et al. (8) reported that
CTLA-4 localizes within the raft. Given our previous stud-
ies demonstrating the interaction of CTLA-4 with the
TCR
 
 
 
 chain, we hypothesized that CTLA-4 may nega-
tively regulate lipid raft signaling. As a first step in address-
ing this issue, we examined the distribution of CTLA-4
within the rafts. The Jurkat T cell line was used for these
studies. Lysates from Jurkat cells, stably transfected with
murine CTLA-4, were subjected to sucrose gradient frac-
tionation. CTLA-4 was immunoprecipitated from each
fraction. As seen in Fig. 1 A, a small fraction of CTLA-4
was constitutively found within the rafts. An anti-phospho-
tyrosine Western blot showed that the raft-associated
CTLA-4 coprecipitated tyrosine phosphorylated bands mi-
grating at 59, 56, 23, and 21 kD (Fig. 1 A, second panel).
The identity of the 59 and 56 kD bands as Fyn and Lck, re-
spectively, were confirmed by reprobing with kinase-spe-
cific antibodies (unpublished data). This observation is
novel and suggests that CTLA-4 interacts within the lipid
rafts as part of a complex that regulates T cell receptor–
mediated signal transduction. The observation builds on
previous work demonstrating the ability of lck and fyn to
phosphorylate CTLA-4 and TCR
 
 
 
 (12, 13, 14). Interest-
ingly, reprobing of the membrane with anti-TCR
 
 
 
 anti-
body (Fig. 1 A, bottom panel). showed that the p21 and
p23 observed with the anti-pTyr detected the phosphory-
lated form of TCR
 
 
 
 only in the lipid raft fractions while
the immunoblot demonstrated that CTLA-4 precipitatedT
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predominantly the nonphosphorylated form of TCR
 
 
 
 from
the non-lipid raft bottom fractions. It is important to note
that the fractions were solubilized by n-octyl 
 
 
 
-D-galacto-
pyranoside to ensure that associations were due to protein–
protein interactions and not copresence within membrane
vesicles. In addition, several control hamster antibodies
were tested to ensure the specificity of the immunoprecipi-
tations (unpublished data).
As Jurkat cells are tumor cells in a quasi activation state,
the physiologic role of TCR stimulation in CTLA-4/raft
interactions was examined using previously activated mu-
rine T cells. CTLA-4 protein was precipitated from the
rafts of nonstimulated and anti-CD3–stimulated T cells and
the association of CTLA-4 with TCR
 
 
 
 was examined.
Upon cross-linking of TCR, the amount of CTLA-4 in
the raft was slightly increased (Fig. 1 B, top right and top
left panel), consistent with the previous findings (8). No
coprecipitation of phosphorylated bands around 21 and 23
kD was observed in the resting T cells (Fig. 1 B, bottom
left panel). However, upon TCR cross-linking, CTLA-4
coprecipitated phosphorylated TCR
 
 
 
 (Fig. 1 B, bottom
right panel). Although 10 times more CTLA-4 protein was
observed outside the rafts, the nonraft CTLA-4 associated
predominantly with nonphosphorylated TCR
 
 
 
 (unpub-
lished data). These results were identical to that observed in
the Jurkat cells. Neither the amount of CTLA-4 protein
nor TCR
 
 
 
 associated CTLA-4 changed upon cross-linking
of TCR (unpublished data). Thus, CTLA-4 interacts with
TCR
 
 
 
 both inside and outside the raft. However, the rela-
tive proportion of the CTLA-4 protein complexed with
phosphorylated TCR
 
 
 
 within the rafts was significantly
greater than the phosphoTCR
 
 
 
/CTLA-4 complexes out-
side the rafts. These results suggest that the CTLA-4/phos-
phoTCR
 
 
 
 interaction may regulate T cell signaling at the
immunologic synapse.
 
Presence of CTLA-4 Alters TCR
 
 
 
 Accumulation within
Rafts.
 
Given the results above, we hypothesized that sig-
naling through CTLA-4 in the raft might affect TCR
phosphorylation or TCR recruitment. Lipid rafts from
CTLA-4 knockout mice versus wild-type littermates were
compared with directly examine the function of CTLA-4
on signaling. To ensure that the T cell populations used in
these studies were naive, CTLA-4 knockout mice were
treated by anti-B7 antibodies to block essential CD28/B7
interactions critical for early activation. Previous studies
have shown that the conditions used in this paper result in
T cell populations that are comparable in terms of cell sur-
face phenotype, cytokine production, and proliferative ca-
pacity (15). Indeed, at the time of sacrifice, knockout mice
looked completely healthy and their lymph nodes and
spleens looked the same as of their littermates in terms of
size (unpublished data). Flow cytometric analyses con-
firmed that the majority of the T cells in this setting were
CD69
 
 
 
CD25
 
 
 
CD62L
 
hi
 
 (unpublished data). Isolated lymph
node cells were activated by anti-CD3 and anti-CD28 an-
tibody for 2 d. After 24 h of cell expansion in the presence
of IL-2, the cell surface raft expression was compared. The
staining of activated T cells with FITC-conjugated cholera
toxin B subunit, as a marker for the surface rafts, demon-
strated that the amount of cell surface raft, ganglioside
GM1, was equivalent in each cell population (Fig. 2 A).
The fact that CTLA-4 expression on the activated T cells
did not influence the raft expression is in contrast to previ-
ous reports that CTLA-4 controls the cell surface raft ex-
Figure 1. CTLA-4 associates with tyrosine phosphorylated TCR  in
the lipid raft. (A) 108 Jurkat T cells, stably transfected with wild-type mu-
rine CTLA-4, were lysed and subjected to sucrose gradient centrifuga-
tion. CTLA-4 was immunoprecipitated (IP) from each fraction and de-
tected by Western blotting (WB) using an anti-CTLA-4 antibody (1st
panel). At the same time, the membrane was probed with an anti-phos-
photyrosine antibody (anti-ptyr: 2nd panel). The blot was stripped and
reprobed by an anti-TCR  antibody (3rd panel). The bottom panel de-
picts the result from cholera toxin horse radish peroxidase dot blot from
each fraction. (B) 108 activated mouse T cells were left untreated or re-
stimulated with anti-CD3 (3  g/ml) antibody. After 5 min incubation,
the cells were lysed and fractionated by sucrose density gradient. CTLA-4
in the raft fraction was immunoprecipitated and detected by polyclonal
CTLA-4 antibody (top panels). TCR  association was detected by anti-
phosphotyrosine antibody (bottom panels).T
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pression during primary T cell activation (16). These results
suggest that CTLA-4 inhibits T cell activation in primary T
cells that is essential for raft formation.
Cell lysates were prepared from wild-type and CTLA-
4KO mice T cells activated with anti-CD3 plus anti-CD28
to compare raft composition using sucrose gradient frac-
tionation and immunoblotting. An anti-Fyn Western blot
(Fig. 2 B, top panel) as well as a peroxidase conjugated
cholera toxin dot blot (Fig. 2 B, second panel) confirmed
that the lipid rafts were successfully isolated in fraction 3 of
cell lysates from knockout mice and littermates. As the raft
fractions contained much less protein than nonraft deter-
gent soluble fraction (17), the TCR
 
 
 
 proteins were en-
riched from each fraction by immunoprecipitation before
subjecting to Western blotting. Anti-phosphotyrosine blot-
ting of the anti-TCR
 
 
 
 immunoprecipitate demonstrated
that there was significantly more phosphorylated TCR
 
 
 
 in
the rafts from CTLA-4 knockout than littermate T cells
(Fig. 2 B, third panel lane 3) while there was only a small
difference in TCR
 
 
 
 in the soluble fraction from knockouts
versus littermates (Fig. 2 B, third panel lane 6, and Fig. 2
C). We do not believe that the absence of CTLA-4 alters
the overall level of protein in the raft fraction as can be seen
in Fig. 2 B, the level of fyn in the raft fraction (using a
whole cell lysate) is unchanged (as shown in Fig. 2 B, top
panel). Similar results were observed when examining
other, but not all, proteins using anti-pTyr blotting. Fi-
nally, as seen in Fig. 2 A the overall cholera toxin staining is
not different between wild-type and knockout cells. More-
over, the results were not due to the increased phosphory-
lation of TCR
 
 
 
 within the rafts, as a direct comparison by
probing with TCR
 
 
 
-specific antibodies demonstrated sig-
nificantly more TCR
 
 
 
 protein in the CTLA-4KO T cells
(Fig. 2 B, fourth and fifth panel, and Fig. 2 C, right panel).
These finding suggest that CTLA-4 negatively regulates
TCR
 
 
 
 accumulation in the raft in fully activated T cells.
 
Functional Consequence of Increased CTLA-4/TCR
 
 
 
 Inter-
action with the Rafts of Activated T Cells.
 
The function of
CTLA-4 costimulation on the raft-associated TCR was ex-
amined by activating T cells with anti-CD3 in the presence
of an anti–CTLA-4 mAb using a cross-linking anti–hamster
antibody as described previously (18). Similar to previous
studies (12), concomitant CD3 and CTLA-4 cross-linking
resulted in significantly reduced tyrosine phosphorylation
of TCR
 
 
 
, CD3
 
 
 
, and LAT as compared with CD3 cross-
linking alone (unpublished data). Activated T cells from B6
mice were subjected to sucrose gradient separation to iso-
late rafts. TCR
 
 
 
 was immunoprecipitated from either the
raft or nonraft fractions and subjected to Western blot anal-
ysis. As shown previously (6), TCR
 
 
 
 accumulation within
the rafts was induced by TCR cross-linking. This accumu-
lation was significantly inhibited by CTLA-4 co-cross-link-
ing as determined by anti-phosphotyrosine blotting (Fig. 3
A, top three panels, and Fig. 3 C, left panel). Reprobing
the membrane using a TCR
 
 
 
-specific antibody showed
that the p16
 
 
 
 band disappeared after CTLA-4-cross-linking
(Fig. 3 A, second three panels). These findings suggest that
either the association of CTLA-4 with TCR
 
 
 
 in the non-
Figure 2. CTLA-4 knockout T cells have more TCR in the raft than
their littermate T cells. (A) CTLA-4 knockout and heterozygote litter-
mate T cells were activated by plate-bound anti-CD3 (1  g/ml) and anti-
CD28 (1  g/ml) for 2 d and rested for 1 d. 106 cells were stained using
different concentrations of cholera toxin FITC (8  g/ml and 1  g/ml)
and analyzed using a flow cytometry. MFI, mean fluorescent intensity.
(B) 10 mg of each lysate from CTLA-4 knockout and littermate T cells,
which have been activated with anti-CD3 plus anti-CD28 as described
for panel A, were subjected to sucrose density gradient separation. The
gradient was divided into six fractions that were analyzed for Fyn (1st
panel) and cholera toxin horseradish peroxidase. TCR  was IP from each
fraction and analyzed by WB using anti-ptyr antibody (3rd panel). The
membrane was stripped and reprobed using an anti-TCR  antibody. The
4th and 5th panels depict short (1 min) and long (10 min) exposure of the
membrane, respectively. (C) The band intensity of the phosphorylated
TCR  in the raft fraction from above experiments was measured by den-
sitometry. The intensity of TCR  in CTLA-4 knockout T cells is shown
as the fold increase as compared with littermate T cells.T
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raft fractions prevents 
 
 
 
-chain phosphorylation and raft
accumulation or that the association of the raft membrane-
associated CTLA-4 alters the phosphorylation state of
TCR
 
 
 
 resulting in dissociation of TCR
 
 
 
 from the signaling
complex.
To confirm that CTLA-4 engagement inhibited TCR
 
 
 
accumulation within the raft, T cells from transgenic (Tg)
mice overexpressing CTLA-4 were compared with trans-
gene negative littermates. Previous studies have shown that
 
the mutation of amino acid 201 from tyrosine to valine re-
sults in a functional CTLA-4 molecule that is constitutively
expressed on the T cell membrane (unpublished data, and
reference 10). T cells from normal B6 or CTLA-4 Tg mice
were activated with anti-CD3 alone or in the presence of
CTLA-4 cross-linking. As can be seen in Fig. 3 B, there
was dramatic inhibition of TCR
 
 
 
 accumulation in the raft
in Tg-expressing T cells based on immunoblotting of anti-
TCR
 
 
 
 precipitates with anti-phosphotyrosine. Cross-link-
ing of anti–class I with anti-CD3 did not result in down-
regulation of TCR
 
 
 
 in the rafts. Similar results were
observed with anti-CD28 (unpublished data). In addition,
although only the relevant bands are shown in the figure,
there were no extraneous bands observed in the rest of the
gel image with the exception of bands consistent with
heavy and light chains of the immunoglobulin used for im-
munoprecipitation. Analysis of TCR  demonstrated an
82% decrease in phosphoTCR  accumulation in the raft
when CTLA-4 was cross-linked with the TCR (Fig. 3 C,
right panel). This compares to only a 28% decrease in the
wild-type B6 T cells reflecting the lower CTLA-4 expres-
sion in this setting (Fig. 3 C, left panel). Interestingly, the
amount of basal phospho-  in the rafts of unstimulated T
cells was lower in Tg  versus control wild-type T cells sug-
gesting that overexpression of CTLA-4 reducing accumu-
lation/retention of pTCR  opposite what was observed in
the CTLA-4KO T cells. Thus, CTLA-4–mediated inhibi-
tion of TCR signaling occurs preferentially within the rafts
as a consequence of reduced TCR accumulation and
TCR  chain phosphorylation.
Studies designed to dissect the molecular mechanism of
CTLA-4–mediated immune regulation have been conflict-
ing. We proposed an “inhibition of proximal signal trans-
duction model” based on the ability of CTLA-4 to interact
directly with TCR complex proteins (12). However, oth-
ers have shown more downstream effects of CTLA-4 en-
Figure 4. A model for CTLA-4–mediated inhibition of TCR associa-
tion to the raft.
Figure 3. CTLA-4 inhibits TCR association to the lipid raft. (A) 108
activated mouse T cells were left untreated or stimulated with anti-CD3
(3  g/ml) plus control hamster antibody (30  g/ml) or anti-CTLA-4 an-
tibodies (30  g/ml) and the lysates were fractionated by sucrose density
gradient centrifugation. TCR  was IP from the raft fractions (top six pan-
els) or from the detergent soluble nonraft fractions (bottom six panels and
detected by WB by either anti-ptyr (top panels) or anti-TCR  antibody.
(B) The experiments described above were performed using CTLA-4
Y201V mutant Tg mice. Phosphotyrosine blot of the raft fractions is
shown. Note that hamster anti–mouse class I antibody was included as a
surface control. (C) The band intensity of the phosphorylated TCR  in
the raft fraction from above experiments was measured by densitometry.
The data is normalized as the fold increase as compared with the back-
ground phosphorylation of   in B6 mice. The results were representative
of eight independent experiments.T
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gagement consistent with a distal role for CTLA-4 function
(19). Some of the difficulty in dissecting the functional basis
of CTLA-4 resides in its complex cell localization with the
great majority residing in intracellular vesicles. However,
the recent studies by several groups demonstrating the lo-
calization of CTLA-4 to the lipid rafts/immunological syn-
apse after T cell activation provided a structural basis for the
proximal signal inhibition model (8, 20). In this study, we
have extended this observation to the functional level.
Based on the results presented, we propose that after T cell
activation, CTLA-4 is induced and translocates from the
intracellular vesicles to the immunological synapse where it
associates with TCR  in the lipid rafts attenuating T cell
signaling. This is most prominent after strong or protracted
T cell agonist signaling as more CTLA-4 is recruited to the
raft/synapse. The accumulation of CTLA-4 in the raft/syn-
apse attenuates the sustained TCR signal by driving TCR
out of raft complex where LAT and lck reside. In addition,
CTLA-4 can associate with nonraft TCR  where it in-
creases the activation threshold by inhibiting TCR associa-
tion to the raft (Fig. 4). These effects are consistent with
the proposed models of CTLA-4 inhibition (21).
Finally, these results leave open the question of how
CTLA-4 regulates the raft association of TCR. There are
at least two possibilities. One is a potential role of CTLA-
4–regulated tyrosine phosphatases to control T cell signal-
ing. Two phosphatases, namely, SHP-1 and SHP-2, have
been suggested in several studies to mediate CTLA-4–
mediated inhibition either directly by dephosphorylating
TCR  (12, 22) or indirectly through dephosphorylation of
the regulatory tyrosine of ZAP-70 (23). During CTLA-4
association to the rafts, the associated phosphatases might
dephosphorylate these important signal components and
subsequently cause dissociation of the raft associated mole-
cules such as Lck, Fyn, LAT, and TCR chain. In fact, tyro-
sine phosphorylation of ZAP70 controls its association to
LAT and Lck, while TCR  phosphorylation is important
for its interaction with Fyn, Lck, and ZAP70. It is also pos-
sible that CTLA-4 might influence the spatial localization
of TCR and coreceptors. The crystal structure of the B7-
CTLA-4 predicts that the intermembrane distance of the
B7-CTLA-4 complex is very similar to that of MHC–
TCR interaction (130–150 Å) but forms highly ordered
oligomers due to their unique dimerization structures (for a
review, see reference 24). Upon CTLA-4 association to the
immunological synapse, the highly ordered CTLA-4-B7
complex may surround TCR complex in the c-SMAC and
limit the accessibility of CD4-Lck complex. In fact, Lck-
associated CD4 coreceptors and ZAP70-associated TCR
differentially cluster during the immunological synapse for-
mation (25). Understanding the spatial relationship of
CTLA-4 and the proximal TCR signaling components will
hopefully help elucidate the molecular mechanism by
which CTLA-4 down-regulates T cell activation.
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